Literature DB >> 23657731

[Expression, identification and experience of emotions in mental diseases. An overview].

K Wolf1, R Maß, M Lambert, K Wiedemann, D Naber.   

Abstract

Several studies in clinical neuroscience have focused on the analysis of expression of emotions, identification of emotions and experience of emotions. These empirical studies produced certain insights into emotional competency in different mental diseases, most of them in schizophrenia. The current article gives a description of the scientific data about alterations in emotional competency in several mental diseases (e.g. schizophrenia, depression, bipolar and borderline diseases) and links the data, if possible, with clinical relevance with a special focus on emotional competency in prodromal schizophrenia.

Entities:  

Mesh:

Year:  2014        PMID: 23657731     DOI: 10.1007/s00115-013-3778-8

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  92 in total

1.  Perceptual bias of patients with schizophrenia in morphed facial expression.

Authors:  Jia Huang; Raymond C K Chan; Jackie K Gollan; Wenhua Liu; Zheng Ma; Zhanjiang Li; Qi-yong Gong
Journal:  Psychiatry Res       Date:  2010-06-19       Impact factor: 3.222

2.  Selective attention to affective stimuli and clinical depression among youths: role of anxiety and specificity of emotion.

Authors:  Benjamin L Hankin; Brandon E Gibb; John R Z Abela; Kate Flory
Journal:  J Abnorm Psychol       Date:  2010-08

3.  Affective-prosodic deficits in schizophrenia: comparison to patients with brain damage and relation to schizophrenic symptoms [corrected].

Authors:  E D Ross; D M Orbelo; J Cartwright; S Hansel; M Burgard; J A Testa; R Buck
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-05       Impact factor: 10.154

4.  Communication of affect in schizophrenia.

Authors:  E Gottheil; A Paredes; R V Exline; R Winkelmayer
Journal:  Arch Gen Psychiatry       Date:  1970-05

5.  Differential impairments in emotion face recognition in postpartum and nonpostpartum depressed women.

Authors:  T John Flanagan; Henry White; Brianne G Carter
Journal:  J Affect Disord       Date:  2010-08-25       Impact factor: 4.839

6.  Emotional reactivity to daily life stress in psychosis and affective disorder: an experience sampling study.

Authors:  I Myin-Germeys; F Peeters; R Havermans; N A Nicolson; M W DeVries; P Delespaul; J Van Os
Journal:  Acta Psychiatr Scand       Date:  2003-02       Impact factor: 6.392

7.  Physiological and self-assessed emotional responses to emotion-eliciting films in borderline personality disorder.

Authors:  Matilde Elices; Joaquim Soler; Cristina Fernández; Ana Martín-Blanco; María Jesús Portella; Víctor Pérez; Enrique Alvarez; Juan Carlos Pascual
Journal:  Psychiatry Res       Date:  2012-08-09       Impact factor: 3.222

8.  On the broad applicability of the affective circumplex: representations of affective knowledge among schizophrenia patients.

Authors:  Ann M Kring; Lisa Feldman Barrett; David E Gard
Journal:  Psychol Sci       Date:  2003-05

Review 9.  Deficits in facial-affect recognition and schizophrenia.

Authors:  R L Morrison; A S Bellack; K T Mueser
Journal:  Schizophr Bull       Date:  1988       Impact factor: 9.306

10.  Spatial processing of facial emotion in patients with unipolar depression: a longitudinal study.

Authors:  Thomas Suslow; Udo Dannlowski; Judith Lalee-Mentzel; Uta-Susan Donges; Volker Arolt; Anette Kersting
Journal:  J Affect Disord       Date:  2004-11-15       Impact factor: 4.839

View more
  2 in total

1.  The current conceptualization of negative symptoms in schizophrenia.

Authors:  Stephen R Marder; Silvana Galderisi
Journal:  World Psychiatry       Date:  2017-02       Impact factor: 49.548

2.  Impairments of Social Interaction in Depressive Disorder.

Authors:  Erhan Akinci; Max-Oskar Wieser; Simon Vanscheidt; Shirin Diop; Vera Flasbeck; Burhan Akinci; Cora Stiller; Georg Juckel; Paraskevi Mavrogiorgou
Journal:  Psychiatry Investig       Date:  2022-02-25       Impact factor: 2.505

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.